FGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells

European Journal of Clinical Investigation

Volumn 44, Issue 8, 2014, Pages 795-801

  Kao, Yu Hsun ^a,b   Chen, Yao Chang ^c   Lin, Yung Kuo ^a   Shiu, Rong Jie ^b   Chao, Tze Fan ^d   Chen, Shih Ann ^d,e   Chen, Yi Jen ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Atrial arrhythmogenesis; Calcium handling protein; Calcium calmodulin dependent protein kinase II; Fibroblast growth factor 23

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA; CALCIUM CHANNEL L TYPE; FIBROBLAST GROWTH FACTOR 23; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SERINE; THREONINE; UNCLASSIFIED DRUG; 1-(6-((3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL)AMINO)HEXYL)-1H-PYRROLE-2,5-DIONE; 2 PYRROLIDONE DERIVATIVE; CALCIUM BINDING PROTEIN; ESTRANE DERIVATIVE; FIBROBLAST GROWTH FACTOR; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; SODIUM CALCIUM EXCHANGE PROTEIN; SULFONAMIDE;

AFTERDEPOLARIZATION; ANIMAL CELL; ARRHYTHMOGENESIS; ARTICLE; ATRIAL MYOCYTE; CALCIUM CURRENT; CALCIUM HOMEOSTASIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEPOLARIZATION; ENZYME PHOSPHORYLATION; FLUORESCENCE IMAGING; HEART ATRIUM; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOPLASMIC RETICULUM; WESTERN BLOTTING; WHOLE CELL PATCH CLAMP; ACTION POTENTIAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; HEART ARRHYTHMIA; HOMEOSTASIS; HUMAN; METABOLISM; PATCH CLAMP TECHNIQUE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACTION POTENTIALS; ARRHYTHMIAS, CARDIAC; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRENES; FIBROBLAST GROWTH FACTORS; HEART ATRIA; HOMEOSTASIS; HUMANS; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; PYRROLIDINONES; SODIUM-CALCIUM EXCHANGER; SULFONAMIDES;

EID: 84904569418     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12296     Document Type: Article

References (34)

1. Razzaque MS. The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol 2009;5:611-9.
2. Torres PU, Prie D, Molina-Bletry V, Beck L, Silve C, Friedlander G. Klotho: an antiaging protein involved in mineral and vitamin D metabolism. Kidney Int 2007;71:730-7.
3. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008;359:584-92.
4. Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A et al. FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 2004;65:1943-6.
5. Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003;64:2272-9.
6. Ix JH, Katz R, Kestenbaum BR, de Boer IH, Chonchol M, Mukamal KJ et al. Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol 2012;60:200-7.
7. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011;121:4393-408.
8. Jin H, Chemaly ER, Lee A, Kho C, Hadri L, Hajjar RJ et al. Mechanoelectrical remodeling and arrhythmias during progression of hypertrophy. FASEB J 2010;24:451-63.
9. van Borren M, Vos M, Houtman M, Antoons G, Ravesloot JH. Increased sarcolemmal Na+/H+ exchange activity in hypertrophied myocytes from dogs with chronic atrioventricular block. Front Physiol 2013;4:322.
10. van Oort RJ, McCauley MD, Dixit SS, Pereira L, Yang Y, Respress JL et al. Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 2010;122:2669-79.
11. Touchberry CD, Green TM, Tchikrizov V, Mannix JE, Mao TF, Carney BW et al. FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy. Am J Physiol Endocrinol Metab 2013;304:E863-73.
12. Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 2011;22:349-57.
13. White SM, Constantin PE, Claycomb WC. Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol 2004;286:H823-9.
14. Tsai W-C, Chen Y-C, Kao Y-H, Lu Y-Y, Chen S-A, Chen Y-J. Distinctive sodium and calcium regulation associated with sex differences in atrial electrophysiology of rabbits. Int J Cardiol 2013;168:4658-66.
15. Huang CF, Chen YC, Yeh HI, Chen SA. Mononucleated and binucleated cardiomyocytes in left atrium and pulmonary vein have different electrical activity and calcium dynamics. Prog Biophys Mol Biol 2012;108:64-73.
16. Juppner H. Phosphate and FGF-23. Kidney Int Suppl 2011;79:S24-7.
17. Quarles LD. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol 2012;8:276-86.
18. Pöss J, Mahfoud F, Seiler S, Heine GH, Fliser D, Böhm M et al. FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock. Eur Heart J Acute Cardiovasc Care 2013;2:211-8.
19. Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G et al. FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 2011;22:1913-22.
20. Hsu HJ, Wu MS. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 2009;337:116-22.
21. Roberts PR, Green D. Arrhythmias in chronic kidney disease. Heart 2011;97:766-73.
22. Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, Xie H et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011;79:1370-8.
23. Seiler S, Heine GH, Fliser D. Clinical relevance of FGF-23 in chronic kidney disease. Kidney Int Suppl 2009;76:S34-42.
24. Baber U, Howard VJ, Halperin JL, Soliman EZ, Zhang X, McClellan W et al. Association of chronic kidney disease with atrial fibrillation among adults in the united states: reasons for geographic and racial differences in stroke (REGARDS) study. Circ Arrhythm Electrophysiol 2011;4:26-32.
25. Hove-Madsen L, Llach A, Bayes-Genis A, Roura S, Rodriguez FontE, Aris A et al. Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 2004;110:1358-63.
26. Huke S, Bers DM. Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes. Biochem Biophys Res Commun 2008;376:80-5.
27. Periasamy M, Bhupathy P, Babu GJ. Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology. Cardiovasc Res 2008;77:265-73.
28. Bidwell P, Blackwell DJ, Hou Z, Zima AV, Robia SL. Phospholamban binds with differential affinity to calcium pump conformers. J Biol Chem 2011;286:35044-50.
29. Voigt N, Heijman J, Wang Q, Chiang DY, Li N, Karck M et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation 2014;129:145-56.
30. Zhang W, Xu C. Calcium sensing receptor and heart diseases. Pathophysiology 2009;16:317-23.
31. Zhang T, Brown JH. Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res 2004;63:476-86.
32. Luo M, Anderson ME. Mechanisms of altered Ca2+ handling in heart Failure. Circ Res 2013;113:690-708.
33. Erickson JR, Anderson ME. CaMKII and its role in cardiac arrhythmia. J Cardiovasc Electrophysiol 2008;19:1332-6.
34. Mohler PJ, Hund TJ. Role of CaMKII in cardiovascular health, disease, and arrhythmia. Heart Rhythm 2011;8:142-4.